Jerry O. Stern

A Comprehensive Hepatic Safety Analysis of Nevirapine in Different Populations of HIV Infected Patients*

Jerry O. Stern, Patrick Robinson, James E. Love et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 237 citations

Pharmacotherapy, Antiviral Drug, Autoimmune Liver Disease +20

Drug-Induced Liver Injury Associated with the Use of Nonnucleoside Reverse-Transcriptase Inhibitors

Douglas T. Dieterich, Patrick Robinson, Joanna Love et al. · Clinical Infectious Diseases · 2004 · 205 citations · Full text

Immunology, Pathology, Pharmacotherapy +18

Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127, and Ribavirin in Patients With Chronic HCV Infection

Stefan Zeuzem, Tarik Asselah, Peter Angus et al. · Gastroenterology · 2011 · 133 citations · Full text

Hepatology, Viral Hepatitis, Antiviral Drug Development +8

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

Michael P. Manns, Marc Bourlière, Yves Benhamou et al. · Journal of Hepatology · 2010 · 112 citations

Viral Hepatitis, Antiviral Drug Development, Antiviral Therapy +6

Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial

Mark Sulkowski, Tarik Asselah, Jacob Lalezari et al. · Hepatology · 2013 · 104 citations